|
Clinical News & Knowledge: Neurology
May 26, 2009 Mr A is a 73-year-old resident of a nursing home, where the irate aides describe him as “a liar and a troublemaker.” Mr A had been a successful and well-liked businessman until 2 years ago, when he sustained a stroke secondary to a ruptured aneurysm of the anterior communicating artery. Prominent memory deficits ensued. Mr A also became irritable, verbally abusive, and “hard to manage.” Staff also complained that Mr A “made up stories about the staff, just to get us in trouble . . . like, that... More » June 1, 2007 AC-1202 Improves Cognition in APOE*E4-Negative Patients with AD. A medium chain triglyceride that converts to ketone bodies and counteracts reduced glucose metabolism improves cognitive scores in patients with mild to moderate Alzheimer disease (AD) who do not have the e4 allele of the apolipoprotein E (APOE*E4) gene. More » May 1, 2007 Personality Traits Early Clue to Distinguishing LBD From AD. Lewy body dementia (LBD) is often difficult to distinguish from Alzheimer disease (AD) but subtleties in symptoms provide clues to the differential diagnosis. More » January 8, 2007 BOSTON -- Clinical and research developments in neurology in 2006 seemed to be as much about prevention as treatment. More » November 1, 2005 Two new recommendation papers--one on the use of serum prolactin (PRL) in the differential diagnosis of epileptiform seizures and the other on use of carotid endarterectomy (CE) in stroke prevention--were released this past September by subcommittees of the American Academy of Neurology (AAN). More » October 1, 2005 September 1, 2005 A team of neuroscientists from Purdue University and Nagoya University in Nagoya, Japan, has identified acrolein as a key neurotoxin in the neurodegenerative process that follows traumatic spinal cord injury. Acrolein, a toxic industrial by-product, naturally occurs in the body in negligible quantities as free radical molecules. However, it can quickly accrue to toxic levels in response to trauma, stress, or exposure to environmental carcinogens. Carriage More » September 1, 2005 general neurology More »July 1, 2005 Subspecialization within the practice of neurology is now reality with the recent approvals of subspecialty designations for neuromuscular pathology, headache medicine, and neuro-oncology. The American Academy of Neurology (AAN) Committee on Neuromuscular Pathology sponsored the neuromuscular pathology membership application. Two associations--the AAN Headache and Facial Pain Section and the American Headache Society--sponsored the headache medicine application. More » July 1, 2005 An estimated 18,500 cases of primary cancer of the brain and CNS will be diagnosed this year, according to the American Cancer Society (Cancer Facts and Figures 2005; More » |
|
CancerNetwork |
ConsultantLive |
Diagnostic Imaging |
Psychiatric Times |
Physicians Practice |
SearchMedica
© 1996 - 2009 CMPMedica LLC, a
United Business Media company
Privacy Statement -
Terms of Service -
Advertising Information
